The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Small Molecule CXO Market Research Report 2025
Synopsis
The global Small Molecule CXO market was valued at US$ 48290 million in 2023 and is anticipated to reach US$ 119030 million by 2030, witnessing a CAGR of 14.2% during the forecast period 2024-2030.
North American market for Small Molecule CXO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule CXO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Molecule CXO in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Molecule CXO include IQVIA, Labcorp, PPD, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing and Porton Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule CXO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule CXO.
Report Scope
The Small Molecule CXO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule CXO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule CXO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IQVIA
Labcorp
PPD
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Tigermed
Shanghai Medicilon
VIVA Biotech Holdings
Chengdu Hitgen
Nanjing Genscript
ICON plc
PRA Health
Syneos Health
Lonza
Catalent
Thermo Fisher
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Segment by Type
CRO
CMC
CDMO
CMO
Segment by Application
Pharmaceutical
Biotechnology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule CXO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Small Molecule CXO market was valued at US$ 48290 million in 2023 and is anticipated to reach US$ 119030 million by 2030, witnessing a CAGR of 14.2% during the forecast period 2024-2030.
North American market for Small Molecule CXO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule CXO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Molecule CXO in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Molecule CXO include IQVIA, Labcorp, PPD, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing and Porton Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule CXO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule CXO.
Report Scope
The Small Molecule CXO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule CXO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule CXO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IQVIA
Labcorp
PPD
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Tigermed
Shanghai Medicilon
VIVA Biotech Holdings
Chengdu Hitgen
Nanjing Genscript
ICON plc
PRA Health
Syneos Health
Lonza
Catalent
Thermo Fisher
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Segment by Type
CRO
CMC
CDMO
CMO
Segment by Application
Pharmaceutical
Biotechnology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule CXO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule CXO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CRO
1.2.3 CMC
1.2.4 CDMO
1.2.5 CMO
1.3 Market by Application
1.3.1 Global Small Molecule CXO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule CXO Market Perspective (2019-2030)
2.2 Small Molecule CXO Growth Trends by Region
2.2.1 Global Small Molecule CXO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Small Molecule CXO Historic Market Size by Region (2019-2024)
2.2.3 Small Molecule CXO Forecasted Market Size by Region (2025-2030)
2.3 Small Molecule CXO Market Dynamics
2.3.1 Small Molecule CXO Industry Trends
2.3.2 Small Molecule CXO Market Drivers
2.3.3 Small Molecule CXO Market Challenges
2.3.4 Small Molecule CXO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule CXO Players by Revenue
3.1.1 Global Top Small Molecule CXO Players by Revenue (2019-2024)
3.1.2 Global Small Molecule CXO Revenue Market Share by Players (2019-2024)
3.2 Global Small Molecule CXO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Molecule CXO Revenue
3.4 Global Small Molecule CXO Market Concentration Ratio
3.4.1 Global Small Molecule CXO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule CXO Revenue in 2023
3.5 Small Molecule CXO Key Players Head office and Area Served
3.6 Key Players Small Molecule CXO Product Solution and Service
3.7 Date of Enter into Small Molecule CXO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule CXO Breakdown Data by Type
4.1 Global Small Molecule CXO Historic Market Size by Type (2019-2024)
4.2 Global Small Molecule CXO Forecasted Market Size by Type (2025-2030)
5 Small Molecule CXO Breakdown Data by Application
5.1 Global Small Molecule CXO Historic Market Size by Application (2019-2024)
5.2 Global Small Molecule CXO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Small Molecule CXO Market Size (2019-2030)
6.2 North America Small Molecule CXO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Small Molecule CXO Market Size by Country (2019-2024)
6.4 North America Small Molecule CXO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule CXO Market Size (2019-2030)
7.2 Europe Small Molecule CXO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Small Molecule CXO Market Size by Country (2019-2024)
7.4 Europe Small Molecule CXO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule CXO Market Size (2019-2030)
8.2 Asia-Pacific Small Molecule CXO Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Small Molecule CXO Market Size by Region (2019-2024)
8.4 Asia-Pacific Small Molecule CXO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule CXO Market Size (2019-2030)
9.2 Latin America Small Molecule CXO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Small Molecule CXO Market Size by Country (2019-2024)
9.4 Latin America Small Molecule CXO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule CXO Market Size (2019-2030)
10.2 Middle East & Africa Small Molecule CXO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Small Molecule CXO Market Size by Country (2019-2024)
10.4 Middle East & Africa Small Molecule CXO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Detail
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Small Molecule CXO Introduction
11.1.4 IQVIA Revenue in Small Molecule CXO Business (2019-2024)
11.1.5 IQVIA Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Detail
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Small Molecule CXO Introduction
11.2.4 Labcorp Revenue in Small Molecule CXO Business (2019-2024)
11.2.5 Labcorp Recent Development
11.3 PPD
11.3.1 PPD Company Detail
11.3.2 PPD Business Overview
11.3.3 PPD Small Molecule CXO Introduction
11.3.4 PPD Revenue in Small Molecule CXO Business (2019-2024)
11.3.5 PPD Recent Development
11.4 Wuxi Apptec
11.4.1 Wuxi Apptec Company Detail
11.4.2 Wuxi Apptec Business Overview
11.4.3 Wuxi Apptec Small Molecule CXO Introduction
11.4.4 Wuxi Apptec Revenue in Small Molecule CXO Business (2019-2024)
11.4.5 Wuxi Apptec Recent Development
11.5 PharmaBlock
11.5.1 PharmaBlock Company Detail
11.5.2 PharmaBlock Business Overview
11.5.3 PharmaBlock Small Molecule CXO Introduction
11.5.4 PharmaBlock Revenue in Small Molecule CXO Business (2019-2024)
11.5.5 PharmaBlock Recent Development
11.6 Asym Chemical
11.6.1 Asym Chemical Company Detail
11.6.2 Asym Chemical Business Overview
11.6.3 Asym Chemical Small Molecule CXO Introduction
11.6.4 Asym Chemical Revenue in Small Molecule CXO Business (2019-2024)
11.6.5 Asym Chemical Recent Development
11.7 Jiuzhou Pharmaceutical
11.7.1 Jiuzhou Pharmaceutical Company Detail
11.7.2 Jiuzhou Pharmaceutical Business Overview
11.7.3 Jiuzhou Pharmaceutical Small Molecule CXO Introduction
11.7.4 Jiuzhou Pharmaceutical Revenue in Small Molecule CXO Business (2019-2024)
11.7.5 Jiuzhou Pharmaceutical Recent Development
11.8 Pharmaron Beijing
11.8.1 Pharmaron Beijing Company Detail
11.8.2 Pharmaron Beijing Business Overview
11.8.3 Pharmaron Beijing Small Molecule CXO Introduction
11.8.4 Pharmaron Beijing Revenue in Small Molecule CXO Business (2019-2024)
11.8.5 Pharmaron Beijing Recent Development
11.9 Porton Pharma
11.9.1 Porton Pharma Company Detail
11.9.2 Porton Pharma Business Overview
11.9.3 Porton Pharma Small Molecule CXO Introduction
11.9.4 Porton Pharma Revenue in Small Molecule CXO Business (2019-2024)
11.9.5 Porton Pharma Recent Development
11.10 ChemPartner
11.10.1 ChemPartner Company Detail
11.10.2 ChemPartner Business Overview
11.10.3 ChemPartner Small Molecule CXO Introduction
11.10.4 ChemPartner Revenue in Small Molecule CXO Business (2019-2024)
11.10.5 ChemPartner Recent Development
11.11 Tigermed
11.11.1 Tigermed Company Detail
11.11.2 Tigermed Business Overview
11.11.3 Tigermed Small Molecule CXO Introduction
11.11.4 Tigermed Revenue in Small Molecule CXO Business (2019-2024)
11.11.5 Tigermed Recent Development
11.12 Shanghai Medicilon
11.12.1 Shanghai Medicilon Company Detail
11.12.2 Shanghai Medicilon Business Overview
11.12.3 Shanghai Medicilon Small Molecule CXO Introduction
11.12.4 Shanghai Medicilon Revenue in Small Molecule CXO Business (2019-2024)
11.12.5 Shanghai Medicilon Recent Development
11.13 VIVA Biotech Holdings
11.13.1 VIVA Biotech Holdings Company Detail
11.13.2 VIVA Biotech Holdings Business Overview
11.13.3 VIVA Biotech Holdings Small Molecule CXO Introduction
11.13.4 VIVA Biotech Holdings Revenue in Small Molecule CXO Business (2019-2024)
11.13.5 VIVA Biotech Holdings Recent Development
11.14 Chengdu Hitgen
11.14.1 Chengdu Hitgen Company Detail
11.14.2 Chengdu Hitgen Business Overview
11.14.3 Chengdu Hitgen Small Molecule CXO Introduction
11.14.4 Chengdu Hitgen Revenue in Small Molecule CXO Business (2019-2024)
11.14.5 Chengdu Hitgen Recent Development
11.15 Nanjing Genscript
11.15.1 Nanjing Genscript Company Detail
11.15.2 Nanjing Genscript Business Overview
11.15.3 Nanjing Genscript Small Molecule CXO Introduction
11.15.4 Nanjing Genscript Revenue in Small Molecule CXO Business (2019-2024)
11.15.5 Nanjing Genscript Recent Development
11.16 ICON plc
11.16.1 ICON plc Company Detail
11.16.2 ICON plc Business Overview
11.16.3 ICON plc Small Molecule CXO Introduction
11.16.4 ICON plc Revenue in Small Molecule CXO Business (2019-2024)
11.16.5 ICON plc Recent Development
11.17 PRA Health
11.17.1 PRA Health Company Detail
11.17.2 PRA Health Business Overview
11.17.3 PRA Health Small Molecule CXO Introduction
11.17.4 PRA Health Revenue in Small Molecule CXO Business (2019-2024)
11.17.5 PRA Health Recent Development
11.18 Syneos Health
11.18.1 Syneos Health Company Detail
11.18.2 Syneos Health Business Overview
11.18.3 Syneos Health Small Molecule CXO Introduction
11.18.4 Syneos Health Revenue in Small Molecule CXO Business (2019-2024)
11.18.5 Syneos Health Recent Development
11.19 Lonza
11.19.1 Lonza Company Detail
11.19.2 Lonza Business Overview
11.19.3 Lonza Small Molecule CXO Introduction
11.19.4 Lonza Revenue in Small Molecule CXO Business (2019-2024)
11.19.5 Lonza Recent Development
11.20 Catalent
11.20.1 Catalent Company Detail
11.20.2 Catalent Business Overview
11.20.3 Catalent Small Molecule CXO Introduction
11.20.4 Catalent Revenue in Small Molecule CXO Business (2019-2024)
11.20.5 Catalent Recent Development
11.21 Thermo Fisher
11.21.1 Thermo Fisher Company Detail
11.21.2 Thermo Fisher Business Overview
11.21.3 Thermo Fisher Small Molecule CXO Introduction
11.21.4 Thermo Fisher Revenue in Small Molecule CXO Business (2019-2024)
11.21.5 Thermo Fisher Recent Development
11.22 DELPHARM
11.22.1 DELPHARM Company Detail
11.22.2 DELPHARM Business Overview
11.22.3 DELPHARM Small Molecule CXO Introduction
11.22.4 DELPHARM Revenue in Small Molecule CXO Business (2019-2024)
11.22.5 DELPHARM Recent Development
11.23 Aenova Group
11.23.1 Aenova Group Company Detail
11.23.2 Aenova Group Business Overview
11.23.3 Aenova Group Small Molecule CXO Introduction
11.23.4 Aenova Group Revenue in Small Molecule CXO Business (2019-2024)
11.23.5 Aenova Group Recent Development
11.24 Siegfried Holding AG
11.24.1 Siegfried Holding AG Company Detail
11.24.2 Siegfried Holding AG Business Overview
11.24.3 Siegfried Holding AG Small Molecule CXO Introduction
11.24.4 Siegfried Holding AG Revenue in Small Molecule CXO Business (2019-2024)
11.24.5 Siegfried Holding AG Recent Development
11.25 Recipharm AB
11.25.1 Recipharm AB Company Detail
11.25.2 Recipharm AB Business Overview
11.25.3 Recipharm AB Small Molecule CXO Introduction
11.25.4 Recipharm AB Revenue in Small Molecule CXO Business (2019-2024)
11.25.5 Recipharm AB Recent Development
11.26 FAREVA SA
11.26.1 FAREVA SA Company Detail
11.26.2 FAREVA SA Business Overview
11.26.3 FAREVA SA Small Molecule CXO Introduction
11.26.4 FAREVA SA Revenue in Small Molecule CXO Business (2019-2024)
11.26.5 FAREVA SA Recent Development
11.27 Almac Group
11.27.1 Almac Group Company Detail
11.27.2 Almac Group Business Overview
11.27.3 Almac Group Small Molecule CXO Introduction
11.27.4 Almac Group Revenue in Small Molecule CXO Business (2019-2024)
11.27.5 Almac Group Recent Development
11.28 Cambrex
11.28.1 Cambrex Company Detail
11.28.2 Cambrex Business Overview
11.28.3 Cambrex Small Molecule CXO Introduction
11.28.4 Cambrex Revenue in Small Molecule CXO Business (2019-2024)
11.28.5 Cambrex Recent Development
11.29 Charles River
11.29.1 Charles River Company Detail
11.29.2 Charles River Business Overview
11.29.3 Charles River Small Molecule CXO Introduction
11.29.4 Charles River Revenue in Small Molecule CXO Business (2019-2024)
11.29.5 Charles River Recent Development
11.30 CORDEN PHARMA
11.30.1 CORDEN PHARMA Company Detail
11.30.2 CORDEN PHARMA Business Overview
11.30.3 CORDEN PHARMA Small Molecule CXO Introduction
11.30.4 CORDEN PHARMA Revenue in Small Molecule CXO Business (2019-2024)
11.30.5 CORDEN PHARMA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Small Molecule CXO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CRO
Table 3. Key Players of CMC
Table 4. Key Players of CDMO
Table 5. Key Players of CMO
Table 6. Global Small Molecule CXO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Small Molecule CXO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Small Molecule CXO Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Small Molecule CXO Market Share by Region (2019-2024)
Table 10. Global Small Molecule CXO Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Small Molecule CXO Market Share by Region (2025-2030)
Table 12. Small Molecule CXO Market Trends
Table 13. Small Molecule CXO Market Drivers
Table 14. Small Molecule CXO Market Challenges
Table 15. Small Molecule CXO Market Restraints
Table 16. Global Small Molecule CXO Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Small Molecule CXO Market Share by Players (2019-2024)
Table 18. Global Top Small Molecule CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CXO as of 2023)
Table 19. Ranking of Global Top Small Molecule CXO Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Small Molecule CXO Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Small Molecule CXO Product Solution and Service
Table 23. Date of Enter into Small Molecule CXO Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Small Molecule CXO Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Small Molecule CXO Revenue Market Share by Type (2019-2024)
Table 27. Global Small Molecule CXO Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Small Molecule CXO Revenue Market Share by Type (2025-2030)
Table 29. Global Small Molecule CXO Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Small Molecule CXO Revenue Market Share by Application (2019-2024)
Table 31. Global Small Molecule CXO Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Small Molecule CXO Revenue Market Share by Application (2025-2030)
Table 33. North America Small Molecule CXO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Small Molecule CXO Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Small Molecule CXO Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Small Molecule CXO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Small Molecule CXO Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Small Molecule CXO Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Small Molecule CXO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Small Molecule CXO Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Small Molecule CXO Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Small Molecule CXO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Small Molecule CXO Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Small Molecule CXO Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Small Molecule CXO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Small Molecule CXO Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Small Molecule CXO Market Size by Country (2025-2030) & (US$ Million)
Table 48. IQVIA Company Detail
Table 49. IQVIA Business Overview
Table 50. IQVIA Small Molecule CXO Product
Table 51. IQVIA Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 52. IQVIA Recent Development
Table 53. Labcorp Company Detail
Table 54. Labcorp Business Overview
Table 55. Labcorp Small Molecule CXO Product
Table 56. Labcorp Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 57. Labcorp Recent Development
Table 58. PPD Company Detail
Table 59. PPD Business Overview
Table 60. PPD Small Molecule CXO Product
Table 61. PPD Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 62. PPD Recent Development
Table 63. Wuxi Apptec Company Detail
Table 64. Wuxi Apptec Business Overview
Table 65. Wuxi Apptec Small Molecule CXO Product
Table 66. Wuxi Apptec Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 67. Wuxi Apptec Recent Development
Table 68. PharmaBlock Company Detail
Table 69. PharmaBlock Business Overview
Table 70. PharmaBlock Small Molecule CXO Product
Table 71. PharmaBlock Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 72. PharmaBlock Recent Development
Table 73. Asym Chemical Company Detail
Table 74. Asym Chemical Business Overview
Table 75. Asym Chemical Small Molecule CXO Product
Table 76. Asym Chemical Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 77. Asym Chemical Recent Development
Table 78. Jiuzhou Pharmaceutical Company Detail
Table 79. Jiuzhou Pharmaceutical Business Overview
Table 80. Jiuzhou Pharmaceutical Small Molecule CXO Product
Table 81. Jiuzhou Pharmaceutical Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 82. Jiuzhou Pharmaceutical Recent Development
Table 83. Pharmaron Beijing Company Detail
Table 84. Pharmaron Beijing Business Overview
Table 85. Pharmaron Beijing Small Molecule CXO Product
Table 86. Pharmaron Beijing Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 87. Pharmaron Beijing Recent Development
Table 88. Porton Pharma Company Detail
Table 89. Porton Pharma Business Overview
Table 90. Porton Pharma Small Molecule CXO Product
Table 91. Porton Pharma Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 92. Porton Pharma Recent Development
Table 93. ChemPartner Company Detail
Table 94. ChemPartner Business Overview
Table 95. ChemPartner Small Molecule CXO Product
Table 96. ChemPartner Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 97. ChemPartner Recent Development
Table 98. Tigermed Company Detail
Table 99. Tigermed Business Overview
Table 100. Tigermed Small Molecule CXO Product
Table 101. Tigermed Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 102. Tigermed Recent Development
Table 103. Shanghai Medicilon Company Detail
Table 104. Shanghai Medicilon Business Overview
Table 105. Shanghai Medicilon Small Molecule CXO Product
Table 106. Shanghai Medicilon Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 107. Shanghai Medicilon Recent Development
Table 108. VIVA Biotech Holdings Company Detail
Table 109. VIVA Biotech Holdings Business Overview
Table 110. VIVA Biotech Holdings Small Molecule CXO Product
Table 111. VIVA Biotech Holdings Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 112. VIVA Biotech Holdings Recent Development
Table 113. Chengdu Hitgen Company Detail
Table 114. Chengdu Hitgen Business Overview
Table 115. Chengdu Hitgen Small Molecule CXO Product
Table 116. Chengdu Hitgen Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 117. Chengdu Hitgen Recent Development
Table 118. Nanjing Genscript Company Detail
Table 119. Nanjing Genscript Business Overview
Table 120. Nanjing Genscript Small Molecule CXO Product
Table 121. Nanjing Genscript Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 122. Nanjing Genscript Recent Development
Table 123. ICON plc Company Detail
Table 124. ICON plc Business Overview
Table 125. ICON plc Small Molecule CXO Product
Table 126. ICON plc Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 127. ICON plc Recent Development
Table 128. PRA Health Company Detail
Table 129. PRA Health Business Overview
Table 130. PRA Health Small Molecule CXO Product
Table 131. PRA Health Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 132. PRA Health Recent Development
Table 133. Syneos Health Company Detail
Table 134. Syneos Health Business Overview
Table 135. Syneos Health Small Molecule CXO Product
Table 136. Syneos Health Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 137. Syneos Health Recent Development
Table 138. Lonza Company Detail
Table 139. Lonza Business Overview
Table 140. Lonza Small Molecule CXO Product
Table 141. Lonza Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 142. Lonza Recent Development
Table 143. Catalent Company Detail
Table 144. Catalent Business Overview
Table 145. Catalent Small Molecule CXO Product
Table 146. Catalent Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 147. Catalent Recent Development
Table 148. Thermo Fisher Company Detail
Table 149. Thermo Fisher Business Overview
Table 150. Thermo Fisher Small Molecule CXO Product
Table 151. Thermo Fisher Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 152. Thermo Fisher Recent Development
Table 153. DELPHARM Company Detail
Table 154. DELPHARM Business Overview
Table 155. DELPHARM Small Molecule CXO Product
Table 156. DELPHARM Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 157. DELPHARM Recent Development
Table 158. Aenova Group Company Detail
Table 159. Aenova Group Business Overview
Table 160. Aenova Group Small Molecule CXO Product
Table 161. Aenova Group Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 162. Aenova Group Recent Development
Table 163. Siegfried Holding AG Company Detail
Table 164. Siegfried Holding AG Business Overview
Table 165. Siegfried Holding AG Small Molecule CXO Product
Table 166. Siegfried Holding AG Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 167. Siegfried Holding AG Recent Development
Table 168. Recipharm AB Company Detail
Table 169. Recipharm AB Business Overview
Table 170. Recipharm AB Small Molecule CXO Product
Table 171. Recipharm AB Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 172. Recipharm AB Recent Development
Table 173. FAREVA SA Company Detail
Table 174. FAREVA SA Business Overview
Table 175. FAREVA SA Small Molecule CXO Product
Table 176. FAREVA SA Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 177. FAREVA SA Recent Development
Table 178. Almac Group Company Detail
Table 179. Almac Group Business Overview
Table 180. Almac Group Small Molecule CXO Product
Table 181. Almac Group Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 182. Almac Group Recent Development
Table 183. Cambrex Company Detail
Table 184. Cambrex Business Overview
Table 185. Cambrex Small Molecule CXO Product
Table 186. Cambrex Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 187. Cambrex Recent Development
Table 188. Charles River Company Detail
Table 189. Charles River Business Overview
Table 190. Charles River Small Molecule CXO Product
Table 191. Charles River Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 192. Charles River Recent Development
Table 193. CORDEN PHARMA Company Detail
Table 194. CORDEN PHARMA Business Overview
Table 195. CORDEN PHARMA Small Molecule CXO Product
Table 196. CORDEN PHARMA Revenue in Small Molecule CXO Business (2019-2024) & (US$ Million)
Table 197. CORDEN PHARMA Recent Development
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule CXO Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Small Molecule CXO Market Share by Type: 2023 VS 2030
Figure 3. CRO Features
Figure 4. CMC Features
Figure 5. CDMO Features
Figure 6. CMO Features
Figure 7. Global Small Molecule CXO Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Small Molecule CXO Market Share by Application: 2023 VS 2030
Figure 9. Pharmaceutical Case Studies
Figure 10. Biotechnology Case Studies
Figure 11. Small Molecule CXO Report Years Considered
Figure 12. Global Small Molecule CXO Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Small Molecule CXO Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Small Molecule CXO Market Share by Region: 2023 VS 2030
Figure 15. Global Small Molecule CXO Market Share by Players in 2023
Figure 16. Global Top Small Molecule CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CXO as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Small Molecule CXO Revenue in 2023
Figure 18. North America Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Small Molecule CXO Market Share by Country (2019-2030)
Figure 20. United States Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Small Molecule CXO Market Share by Country (2019-2030)
Figure 24. Germany Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Small Molecule CXO Market Share by Region (2019-2030)
Figure 32. China Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Small Molecule CXO Market Share by Country (2019-2030)
Figure 40. Mexico Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Small Molecule CXO Market Share by Country (2019-2030)
Figure 44. Turkey Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Small Molecule CXO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. IQVIA Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 47. Labcorp Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 48. PPD Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 49. Wuxi Apptec Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 50. PharmaBlock Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 51. Asym Chemical Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 52. Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 53. Pharmaron Beijing Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 54. Porton Pharma Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 55. ChemPartner Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 56. Tigermed Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 57. Shanghai Medicilon Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 58. VIVA Biotech Holdings Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 59. Chengdu Hitgen Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 60. Nanjing Genscript Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 61. ICON plc Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 62. PRA Health Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 63. Syneos Health Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 64. Lonza Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 65. Catalent Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 66. Thermo Fisher Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 67. DELPHARM Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 68. Aenova Group Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 69. Siegfried Holding AG Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 70. Recipharm AB Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 71. FAREVA SA Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 72. Almac Group Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 73. Cambrex Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 74. Charles River Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 75. CORDEN PHARMA Revenue Growth Rate in Small Molecule CXO Business (2019-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
